NO20006701D0 - Kimkrystaller for fremstilling av peptider eller proteiner - Google Patents

Kimkrystaller for fremstilling av peptider eller proteiner

Info

Publication number: NO20006701D0
Authority: NO; Norway
Prior art keywords: insulin; proteins; microcrystals; peptides; human
Prior art date: 1998-06-30

Application number

NO20006701A

Other languages

English (en)

Other versions

NO20006701L (no

Inventor

Flemming Manique

Christian Ilsoe

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-30

Filing date

2000-12-29

Publication date

2000-12-29

2000-12-29 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2000-12-29 Publication of NO20006701D0 publication Critical patent/NO20006701D0/no

2000-12-29 Publication of NO20006701L publication Critical patent/NO20006701L/no

Links

102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
239000013078 crystal Substances 0.000 title 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 10
102000004877 Insulin Human genes 0.000 abstract 5
108090001061 Insulin Proteins 0.000 abstract 5
229940125396 insulin Drugs 0.000 abstract 5
239000013081 microcrystal Substances 0.000 abstract 5
238000004519 manufacturing process Methods 0.000 abstract 4
101000976075 Homo sapiens Insulin Proteins 0.000 abstract 3
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 3
238000010899 nucleation Methods 0.000 abstract 3
239000000725 suspension Substances 0.000 abstract 3
238000000034 method Methods 0.000 abstract 2
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 abstract 1
102400000321 Glucagon Human genes 0.000 abstract 1
108060003199 Glucagon Proteins 0.000 abstract 1
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 1
102100040918 Pro-glucagon Human genes 0.000 abstract 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 abstract 1
229960004666 glucagon Drugs 0.000 abstract 1
239000000122 growth hormone Substances 0.000 abstract 1
238000000265 homogenisation Methods 0.000 abstract 1
239000011701 zinc Substances 0.000 abstract 1
229910052725 zinc Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
- C30B29/58—Macromolecular compounds
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Diabetes (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Crystallography & Structural Chemistry (AREA)
Zoology (AREA)
Endocrinology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Metallurgy (AREA)
Materials Engineering (AREA)
Chemical Kinetics & Catalysis (AREA)
Obesity (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20006701A 1998-06-30 2000-12-29 Kimkrystaller for fremstilling av peptider eller proteiner NO20006701L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP98610020		1998-06-30
US9288298P	1998-07-15	1998-07-15
PCT/DK1999/000371 WO2000001727A1 (en)	1998-06-30	1999-06-30	Seeding crystals for the preparation of peptides or proteins

Publications (2)

Publication Number	Publication Date
NO20006701D0 true NO20006701D0 (no)	2000-12-29
NO20006701L NO20006701L (no)	2000-12-29

Family

ID=26151840

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20006701A NO20006701L (no)	1998-06-30	2000-12-29	Kimkrystaller for fremstilling av peptider eller proteiner

Country Status (15)

Country	Link
EP (1)	EP1091979B1 (no)
JP (1)	JP2002519437A (no)
KR (1)	KR20010071666A (no)
CN (1)	CN1307589A (no)
AT (1)	ATE340189T1 (no)
AU (1)	AU758496B2 (no)
BR (1)	BR9911678A (no)
CA (1)	CA2336112A1 (no)
DE (1)	DE69933296T2 (no)
ES (1)	ES2273501T3 (no)
HU (1)	HUP0102577A3 (no)
IL (1)	IL140341A0 (no)
NO (1)	NO20006701L (no)
PL (1)	PL345260A1 (no)
WO (1)	WO2000001727A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2686899B1 (fr)	1992-01-31	1995-09-01	Rhone Poulenc Rorer Sa	Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
JP3421739B2 (ja)	2000-03-01	2003-06-30	大阪大学長	有機単結晶の形成方法
EP2213743A1 (en)	2000-04-12	2010-08-04	Human Genome Sciences, Inc.	Albumin fusion proteins
AU2002228608A1 (en) *	2000-12-13	2002-06-24	Eli Lilly And Company	Amidated glucagon-like peptide-1
WO2005003296A2 (en)	2003-01-22	2005-01-13	Human Genome Sciences, Inc.	Albumin fusion proteins
AU2002364586A1 (en)	2001-12-21	2003-07-30	Delta Biotechnology Limited	Albumin fusion proteins
EP2158927A1 (en) *	2008-08-25	2010-03-03	Debiotech S.A.	Drug delivery device with a module for preventing fibrillation downstream of its reservoir
RU2407540C1 (ru) *	2009-06-22	2010-12-27	Общество с ограниченной ответственностью "Завод Медсинтез"	Способ промышленного получения рекомбинантного инсулина человека

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB766994A (en) *	1953-11-13	1957-01-30	Novo Terapeutisk Labortorium A	Improved process in crystallization of insulin
GB766995A (en) *	1953-11-14	1957-01-30	Novo Terapeutisk Labor As	Improvements in or relating to the production of insulin crystals
FR2527903A1 (fr) *	1982-06-03	1983-12-09	Noelle Ancenis Coop Agricole	Procede et installation pour l'obtention d'un produit gras en tout point comparable au beurre
FI882921A7 (fi) *	1986-10-20	1988-06-17	Novo Ind A/S	Protamiinisinkki-insuliinivalmisteet.
BR8803345A (pt) *	1988-06-30	1990-02-13	Biobras Bioquimica Do Brasil S	Processo aperfeicoado para producao em larga escala de cristais de insulina humana purificada
JP2554784B2 (ja) *	1991-03-15	1996-11-13	杏林製薬株式会社	懸濁シロップ剤
NL9201408A (nl) *	1992-08-05	1994-03-01	Holland Sweetener Co	Werkwijze voor het kristalliseren van aspartaam.

1999
- 1999-06-30 IL IL14034199A patent/IL140341A0/xx unknown
- 1999-06-30 PL PL99345260A patent/PL345260A1/xx not_active Application Discontinuation
- 1999-06-30 DE DE69933296T patent/DE69933296T2/de not_active Expired - Lifetime
- 1999-06-30 CA CA002336112A patent/CA2336112A1/en not_active Abandoned
- 1999-06-30 BR BR9911678-2A patent/BR9911678A/pt not_active IP Right Cessation
- 1999-06-30 HU HU0102577A patent/HUP0102577A3/hu unknown
- 1999-06-30 AT AT99931016T patent/ATE340189T1/de not_active IP Right Cessation
- 1999-06-30 JP JP2000558128A patent/JP2002519437A/ja active Pending
- 1999-06-30 AU AU47685/99A patent/AU758496B2/en not_active Ceased
- 1999-06-30 EP EP99931016A patent/EP1091979B1/en not_active Expired - Lifetime
- 1999-06-30 KR KR1020007014921A patent/KR20010071666A/ko not_active Withdrawn
- 1999-06-30 WO PCT/DK1999/000371 patent/WO2000001727A1/en not_active Ceased
- 1999-06-30 ES ES99931016T patent/ES2273501T3/es not_active Expired - Lifetime
- 1999-06-30 CN CN99807953A patent/CN1307589A/zh active Pending
2000
- 2000-12-29 NO NO20006701A patent/NO20006701L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2000001727A1 (en)	2000-01-13
AU4768599A (en)	2000-01-24
BR9911678A (pt)	2001-03-20
JP2002519437A (ja)	2002-07-02
EP1091979B1 (en)	2006-09-20
HUP0102577A2 (hu)	2002-01-28
ATE340189T1 (de)	2006-10-15
CN1307589A (zh)	2001-08-08
KR20010071666A (ko)	2001-07-31
AU758496B2 (en)	2003-03-20
DE69933296T2 (de)	2007-05-03
DE69933296D1 (de)	2006-11-02
HUP0102577A3 (en)	2002-02-28
ES2273501T3 (es)	2007-05-01
CA2336112A1 (en)	2000-01-13
PL345260A1 (en)	2001-12-03
IL140341A0 (en)	2002-02-10
EP1091979A1 (en)	2001-04-18
NO20006701L (no)	2000-12-29

Legal Events

Date	Code	Title	Description
2005-04-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
Nakanishi et al.	1972	Biosynthesis of α and β-ecdysones from cholesterol outside the prothoracic gland in Bombyx mori
ES8600783A1 (es)	1985-11-01	Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.
NO901852L (no)	1990-08-01	Fremgangsmaate for fremstilling av liposomer.
ATE209679T1 (de)	2001-12-15	Proteine mit faktor viii aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende zusammensetzungen
EP0141374A3 (en)	1987-04-15	Capsule production using biologically active substrates
DE69214445D1 (de)	1996-11-14	Gelprodukte und verfahren zu ihrer herstellung
RU95110107A (ru)	1997-05-10	Способ получения стабильного кристаллического аналога цинк-инсулина
DE59410052D1 (de)	2002-03-21	Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DE69103755D1 (de)	1994-10-06	Wachstumshormonkristalle und verfahren zu deren herstellung.
DE69113386D1 (de)	1995-11-02	Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
AU3369299A (en)	1999-11-08	Stable concentrated rare earth carboxylate liquids
DE3881478D1 (de)	1993-07-08	Substituierte carbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende fungizide fuer acker- und gartenbau.
ATE223495T1 (de)	2002-09-15	Saccaridzusammensetzung mit verminderter reduzierbarkeit sowie deren herstellung und verwendung
NO20006701D0 (no)	2000-12-29	Kimkrystaller for fremstilling av peptider eller proteiner
DK1190024T3 (da)	2003-01-13	Druekerner, koldpresset druekerneolie, druekvas og druekernemel
WO2006053761A3 (en)	2007-01-25	Modified plant gums for preparations of active ingredients
DE69001573D1 (de)	1993-06-17	Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
ES2169188T3 (es)	2002-07-01	Produccion de condimento.
ATE308334T1 (de)	2005-11-15	Verfahren zur herstellung von tocotrienol- angereicherten präparationen
ATE139759T1 (de)	1996-07-15	Mittel zur förderung und pflege des pflanzenwachstums und verfahren zu ihrer herstellung
AUPM772494A0 (en)	1994-09-22	Improvements in production of proteins in host cells
AU1355492A (en)	1992-09-07	Method for extracting a biological substance from lepidoptera larvas and substance thus obtained
ES2179835T3 (es)	2003-02-01	Procedimiento para producir seroalbumina humana.
WO2003076595A3 (en)	2004-02-19	Production of insulin and insulin-like proteins in plants
MD1094G2 (ro)	1999-06-30	Metodă de dermatoplastie a plăgilor